PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
115 hedge funds and large institutions have $380M invested in Progenics Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
Holders
115
Holding in Top 10
1
Calls
$1.47M
Puts
$1.02M
Top Buyers
| 1 | +$5.97M | |
| 2 | +$5.63M | |
| 3 | +$3.52M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$3.44M |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$1.77M |
Top Sellers
| 1 | -$13M | |
| 2 | -$3.77M | |
| 3 | -$2.18M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.02M |
| 5 |
RA
Royce & Associates
New York
|
-$1.17M |